Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High Dose Thoracic Re-Irradiation and Chemo-Immunotherapy for Centrally Recurrent NSCLC.
Grambozov B, Stana M, Kaiser B, Karner J, Gerum S, Ruznic E, Zellinger B, Moosbrugger R, Studnicka M, Fastner G, Sedlmayer F, Zehentmayr F. Grambozov B, et al. Among authors: zehentmayr f. Cancers (Basel). 2022 Jan 23;14(3):573. doi: 10.3390/cancers14030573. Cancers (Basel). 2022. PMID: 35158841 Free PMC article. Review.
Preoperative oxaliplatin, capecitabine, and external beam radiotherapy in patients with newly diagnosed, primary operable, cT₃NxM0, low rectal cancer: a phase II study.
Ofner D, Devries AF, Schaberl-Moser R, Greil R, Rabl H, Tschmelitsch J, Zitt M, Kapp KS, Fastner G, Keil F, Eisterer W, Jäger R, Offner F, Gnant M, Thaler J; TAKO 05/ABCSG R-02 Trial Investigators. Ofner D, et al. Strahlenther Onkol. 2011 Feb;187(2):100-7. doi: 10.1007/s00066-010-2182-6. Epub 2011 Jan 21. Strahlenther Onkol. 2011. PMID: 21267531 Clinical Trial.
DART-bid (Dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily)--a novel approach for non-resected NSCLC: final results of a prospective study, correlating radiation dose to tumor volume.
Wurstbauer K, Deutschmann H, Dagn K, Kopp P, Zehentmayr F, Lamprecht B, Porsch P, Wegleitner B, Studnicka M, Sedlmayer F. Wurstbauer K, et al. Among authors: zehentmayr f. Radiat Oncol. 2013 Mar 5;8:49. doi: 10.1186/1748-717X-8-49. Radiat Oncol. 2013. PMID: 23497555 Free PMC article.
IOERT as anticipated tumor bed boost during breast-conserving surgery after neoadjuvant chemotherapy in locally advanced breast cancer--results of a case series after 5-year follow-up.
Fastner G, Reitsamer R, Ziegler I, Zehentmayr F, Fussl C, Kopp P, Peintinger F, Greil R, Fischer T, Deutschmann H, Sedlmayer F. Fastner G, et al. Among authors: zehentmayr f. Int J Cancer. 2015 Mar 1;136(5):1193-201. doi: 10.1002/ijc.29064. Epub 2014 Jul 10. Int J Cancer. 2015. PMID: 24995409 Free article.
Boost IORT in Breast Cancer: Body of Evidence.
Sedlmayer F, Reitsamer R, Fussl C, Ziegler I, Zehentmayr F, Deutschmann H, Kopp P, Fastner G. Sedlmayer F, et al. Among authors: zehentmayr f. Int J Breast Cancer. 2014;2014:472516. doi: 10.1155/2014/472516. Epub 2014 Sep 2. Int J Breast Cancer. 2014. PMID: 25258684 Free PMC article. Review.
46 results